Micofenolato de mofetil Generis 250 mg Cápsulas

A Multicentre, Phase II, Single-Arm, Interventional Study of Neoadjuvant Durvalumab and Platinum-Based Chemotherapy (CT), followed by either Surgery and Adjuvant Durvalumab or Chemoradiotherapy (CRT) and consolidation Durvalumab, in participants with Resectable or Borderline Resectable Stage IIB-IIIB Non-Small Cell Lung Cancer (NSCLC)

A Phase IIIb, Single Arm, Open-label, Multicentre Study of Durvalumab in Combination with Chemotherapy for the First Line Treatment for Patients with Advanced Biliary Tract Cancers (TOURMALINE)

A Phase IIIb, Single Arm, Open-label, Multicentre Study of Durvalumab in Combination with Chemotherapy for the First Line Treatment for Patients with Advanced Biliary Tract Cancers (TOURMALINE)